菲爾德Trip Health(東京證券交易所股票代碼：FTRP)獲得HC Wainwright的買入評級

HC Wainwright reissued their buy rating on shares of Field Trip Health (TSE:FTRP – Get Rating) in a research note issued to investors on Wednesday morning, Stock Target Advisor reports. HC Wainwright currently has a C$25.00 price objective on the stock.

TSE:FTRP opened at C$1.15 on Wednesday. Field Trip Health has a one year low of C$0.93 and a one year high of C$7.90. The company has a debt-to-equity ratio of 31.42, a quick ratio of 8.81 and a current ratio of 9.42. The stock has a market cap of C$66.87 million and a PE ratio of -1.29. The stock has a 50 day moving average price of C$1.11 and a 200 day moving average price of C$1.78.

Get

Field Trip Health

alerts:

About Field Trip Health (Get Rating)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules.

See Also

• 3 Growth Stocks Trading at Value P/E's
• Capri Holdings Stock Looks Attractive For a Premium Retailer
• The Sell-Off In Kornit Digital May Set Up A 2nd Half Opportunity
• Phreesia Stock is a Healthcare IT Play
• Recession Resistant Grocery Outlet Holding Corp Quietly Sets New High

Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.